Eyebiotech
We’re developing therapies aimed at protecting, restoring and improving vision for people living with eye diseases.
Eyebiotech is an AI-native company based in London, United Kingdom, started in 2021. We’re developing therapies aimed at protecting, restoring and improving vision for people living with eye diseases.
- Website
- merck.com
- City
- London
- Country
- United Kingdom
- Founded
- 2021
- AI-native
- Yes
- Registered
- Company 13503296
See it on the London mapSource Spot something wrong?
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in London
Basecamp ResearchLabHiring
Biological data and models from global biodiversity.
Francis Crick InstituteLab
Biomedical discovery institute in central London.
Isomorphic LabsLabMafiaHiring
AI-first drug design spun out of DeepMind.
Latent LabsLabMafiaHiring
Generative models for protein design.
Ochre Bio
RNA medicines for liver diseases
Digistain
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
Claim this profile
Free and instant: prove you run merck.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Eyebiotech across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Eyebiotech's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
